Des tudes dmontrent quune quantit plus importante de Beta-Alanine accrot la concentration de Carnosine musculaire
Studies have shown that GLP-1 agonists can trigger effects in the brain, the heart, the liver, the pancreas, the stomach, and the musclesmeaning that they could have implications for conditions other than type 2 diabetes and obesity, such as heart disease, kidney disease, liver disease, and even neurological conditions such as Alzheimer's disease
Gut microbes 14(1):2102878 Coradduzza D, Sedda S, Cruciani S, De Miglio MR, Ventura C, Nivoli A et al (2023) Age-related cognitive decline, focus on microbiome: a systematic review and meta-analysis
Findings in this timeframe include increases in lean tissue mass and reductions in fat mass, particularly in visceral and abdominal depots, consistent with IGF-1 LR3s documented dual role in anabolic and lipolytic signaling
Remove the cap from the needle
Aches and stiffness that sideline the activities you love
